The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State
Abstract
Recent clinical studies have demonstrated that when morphine is used to control pain in cancer patients, psychological dependence is not a major concern. The present study was undertaken to ascertain the modulation of psychological dependence on morphine under a chronic pain-like state in rats. The prototypical mu-opioid receptor agonist morphine (8 mg/kg, i.p.) induced a dose-dependent place preference. In the present study, we found that an inflammatory pain-like state following formalin injection significantly suppressed the morphine-induced rewarding effect. This effect was almost reversed by s.c. pretreatment with the kappa-opioid receptor antagonist nor-binaltorphimine (nor-BNI, 5 mg/kg). Furthermore, the morphine-induced increase in dopamine (DA) turnover in the limbic forebrain was significantly inhibited by treatment with formalin. This inhibition was also suppressed by pretreatment with nor-BNI. In addition, in vivo microdialysis studies clearly showed that the morphine-induced increase in the extracellular levels of DA and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, in the nucleus accumbens (N.Acc.) was significantly decreased in rats that had been pretreated with formalin. This effect was in turn reversed by the microinjection of a specific dynorphin A antibody into the N.Acc. These findings suggest that the inflammatory pain-like state induced by formalin injection may have caused a sustained activation of the kappa-opioidergic system w…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, although a few mouse studies have shown some increase in drinking with chronic pain in a neuropathic model of pain (González-Sepúlveda et al., 2016) and osteoarthritis model of pain (Butler et al., 2017), the data to date that show increases in the rewarding effects of opioids or increases in opioid self-administration after chronic pain have been limited (Ozaki et al., 2002;Narita et al.”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2005
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Activity-dependent neuronal plasticity following tissue injury and inflammation
Dubner, R., & Ruda, M. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90019-5 · Cited by 926 · cited 2×
“Previous studies have demonstrated that the levels of dynorphin and pre-prodynorphin mRNA in some brain regions are increased under inflammatory pain-like states induced by the injection of carrageenan and complete Freund’s adjuvant (Millan et al, 1987; Dubner and Ruda, 1992).”
BackgroundResultIncreased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286 · cited 7×
“Furthermore, this pain-like state leads to a reduction in m-receptor function in the ventral tegmental area (VTA; Ozaki et al, 2002, 2003), which is the origin of the mesolimbic dopaminergic system and the major neural substrate of the rewarding effect produced by opioids (Koob, 1992; Nestler, 1996; Narita et al, 2001…”
BackgroundInfluentialUnder Siege: The Brain on Opiates
Nestler, E. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80110-5 · Cited by 260
Regulations of opioid dependence by opioid receptor types
Narita, M., Funada, M., & Suzuki, T. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00099-1 · Cited by 190
Self-citationBlockade of morphine reward through the activation of κ-opioid receptors in mice
Funada, M., Suzuki, T., Narita, M., Misawa, M., & Nagase, H. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90026-y · Cited by 166
Self-citation
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Endogenous and Exogenous Opioids in Pain
Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 502
“Inflammatory pain desensitizes MOPR in the VTA, promoting opioid consumption (Hipólito et al. 2015, Narita et al. 2005), and neuropathic pain is accompanied by decreased NAc dopamine release, an effect that involves microglial activation in the VTA (Taylor et al. 2015), as well as other negative…”
BackgroundOpioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
“Indeed, animal and human studies support the contention that opioid euphoria and reward are attenuated by pain (Zacny et al., 1996; Ozaki et al., 2002; Ozaki et al., 2003; Narita et al., 2005; Alford et al., 2006).”
BackgroundAddiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000324065 · Cited by 417
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“…pain-induced attenuation of conditioned place preference can be reversed by the systemic or local NAc blockade of k-opioid receptors using nor-BNI (Narita et al., 2005), and nor-BNI significantly prevented loss of the diffuse noxious inhibitory control response (i.e., a pain-inhibiting pain…”
BackgroundChronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala
Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300858 · Cited by 289
“We also found that an inflammatory pain-like state could cause a sustained activation of the k-opioidergic system in the nucleus accumbens, leading to suppression of the morphine-induced rewarding effect in rats (Suzuki et al, 1999; Narita et al, 2005).”
BackgroundResultSelf-citationTaylor, A. M. W., Becker, S., Schweinhardt, P., & Cahill, C. (2016) · Pain · doi:10.1097/j.pain.0000000000000494 · Cited by 229
“…In fact, the presence of analgesia is required for opioid reward behavior in chronic pain, given that spinally blocking pain interferes with opioid self-administration and CPP. 35,37,38 Equivocal findings have been reported when opioid reward is assessed with the CPP assay, 11,43–45,48, 50, 63, 77”
MethodMassaly, N., Copits, B. A., Wilson-Poe, A. R., Hipólito, L., Markovic, T., Yoon, H. J., Liu, S., Walicki, M. C., Bhatti, D. L., Sirohi, S., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.029 · Cited by 200
Evaluation of reward from pain relief
Navratilova, E., Xie, J. Y., King, T. E., & Porreca, F. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12095 · Cited by 162
Hipólito, L., Wilson‐Poe, A. R., Campos‐Jurado, Y., Zhong, E., González-Romero, J. L., Virag, L., Whittington, R. A., Comer, S. D., Carlton, S. M., Walker, B. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1053-15.2015 · Cited by 125
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain
Liu, S. (., Pickens, S. R., Burma, N. E., Ibarra‐Lecue, I., Yang, H., Xue, L., Cook, C., Hakimian, J. K., Severino, A. L., Lueptow, L. M., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0274-19.2019 · Cited by 118
“One-way ANOVA showed no difference between groups: F(2,15) 0.4558, p 0.642. neuropathic pain states (Narita et al., 2005).”
BackgroundResultInfluentialNarita, M., Nakamura, A., Masahiko, O., Imai, S., Miyoshi, K., Suzuki, M., & Suzuki, T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301471 · Cited by 122
“These persistent painful states caused by sciatic nerve ligation lasted for more than 15 days (Narita et al, 2005b).”
BackgroundSelf-citationNeuropathic and chronic pain stimuli downregulate central μ -opioid and dopaminergic transmission
Niikura, K., Narita, M., Butelman, E. R., Kreek, M. J., & Suzuki, T. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.04.003 · Cited by 120
Self-citationEndogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 110
“In models of neuropathic or inflammatory pain, morphine-induced conditioned place preference (CPP) scores are attenuated but can be restored by intra-NAc infusions of KOPR antagonists (Narita et al., 2005; Liu et al., 2019).”
BackgroundInfluentialKappa opioid antagonists: Past successes and future prospects
Metcalf, M. D., & Coop, A. (2005) · The AAPS Journal · doi:10.1208/aapsj070371 · Cited by 103
Nature vs. nurture: Can enrichment rescue the behavioural phenotype of BDNF heterozygous mice?
Chourbaji, S., Brandwein, C., Vogt, M. A., Dormann, C., Hellweg, R., & Gass, P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.04.015 · Cited by 103
Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction
Gerra, G., Leonardi, C., Cortese, E., D'Amore, A., Lucchini, A., Strepparola, G., Serio, G., Farina, G., Magnelli, F., Zaimovic, A., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30510 · Cited by 90
“, 2003, 2006] and inflammatory pain-like state [Narita et al., 2005].”
BackgroundInfluentialMori, T., Shibasaki, Y., Matsumoto, K., Shibasaki, M., Hasegawa, M., Wang, E., Masukawa, D., Yoshizawa, K., Horie, S., & Suzuki, T. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204313 · Cited by 89
“The antinociceptve response was evaluated by recording the latency to paw licking or tapping in the hot-plate test (55 6 0.5°C; Muromachi Kikai Co., Ltd., Tokyo, Japan) as described previously (Narita et al., 2005).”
MethodSelf-citationMeCP2 Repression of G9a in Regulation of Pain and Morphine Reward
Zhang, Z., Tao, W., Hou, Y.-Y., Wang, W., Kenny, P. J., & Pan, Z. Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-13.2014 · Cited by 90
“…studies reported that animals with pain consumed less opioids in a self-administration model or displayed reduced CPP behavior (Ozaki et al., 2003; Narita et al., 2005; Martin and Ewan, 2008), other studies showed that pain increased opioid self-administration and enhanced CPP behavior (Sufka,…”
BackgroundEndogenous opiates and behavior: 2005
Bodnar, R. J., & Klein, G. E. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.011 · Cited by 96
Bechara, A., Berridge, K. C., Bickel, W. K., Morón, J. A., Williams, S. B., & Stein, J. S. (2019) · Psychological Science in the Public Interest · doi:10.1177/1529100619860513 · Cited by 82
van der Kam, E. L., Vry, J. D., Schiene, K., & Tzschentke, T. (2007) · Pain · doi:10.1016/j.pain.2007.07.027 · Cited by 75
“Narita et al. (2005) have shown that inflammatory agents cause an up-regulation of j-opioid activity, which in turn reduces morphine-induced activation of the mesolimbic dopaminergic system (Narita et al., 2005).”
BackgroundResultPantazis, C. B., Gonzalez, L. A., Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2021) · Science Advances · doi:10.1126/sciadv.abf0364 · Cited by 77
Reward Circuitry Plasticity in Pain Perception and Modulation
DosSantos, M. F. H., Moura, B. D. S., & DaSilva, A. F. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00790 · Cited by 76
“…enhanced function of κ-opoid neurotransmission in the NAc suppressed the effects of µ-opioid receptor agonist morphine (e.g., reward and facilitation of the dopaminergic neurotransmission in mesolimbic neurons), in a model of inflammatory pain induced by formalin injection (Narita et al., 2005).”
BackgroundKuhlman, K. R., Robles, T. F., Dooley, L. N., Boyle, C. C., Haydon, M. D., & Bower, J. E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.001 · Cited by 67
Massaly, N., Morón, J. A., & Al-Hasani, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00480 · Cited by 59
“Most studies have used a conditioned place paradigm to test the reinforcing properties of opioids in rodents undergoing neuropathic or chronic pain (Ozaki et al., 2002; Narita et al., 2005; Cahill et al., 2013; Taylor et al., 2015).”
BackgroundLee, M. C., Wanigasekera, V., & Tracey, I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.035 · Cited by 56
“Sustained activation of the kappa-opioidergic system within the nucleus accumbens is observed in the inflammatory pain state, and is thought to suppress drug-rewarding effects (Narita et al., 2005).”
Kami, K., Tajima, F., & Senba, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-29915-4 · Cited by 79
Rutten, K., Vry, J. D., Robens, A., Tzschentke, T., & van der Kam, E. L. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2010.07.011 · Cited by 52
“…that alterations in pain-depressed behavior can be used as an alternative readout for anti-nociception, e.g. lactic acid-induced pain reduced responding for food or intracranial self stimulation and these reductions were reversed by morphine (Neubert et al., 2005; Pereira Do et al., 2009).”
BackgroundTactile skin stimulation increases dopamine release in the nucleus accumbens in rats
Maruyama, K., Shimoju, R., Ohkubo, M., Maruyama, H., & Kurosawa, M. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0205-z · Cited by 56
“In this context, one should note that the k-opioidergic system or the lopioidergic system suppresses DA release in the NAc in animal models of inflammatory or neuropathic pain [34, 35].”
Zhang, Z., Tao, W., Hou, Y.-Y., Wang, W., Lu, Y.-G., & Pan, Z. Z. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.77 · Cited by 50
“Some studies showed that pain reduced opioid-induced CPP or opioid self-administration (Martin et al, 2007; Narita et al, 2005; Ozaki et al, 2003), but other studies found that pain enhanced opioid CPP and selfadministration (Cahill et al, 2013; Colpaert et al, 2001; Kupers and Gybels, 1995; Sufka,…”
Marchand, S., Bétourné, A., Marty, V., Daumas, S., Halley, H., Lassalle, J., Zajac, J., & Francès, B. (2006) · Peptides · doi:10.1016/j.peptides.2005.07.023 · Cited by 47
Ballantyne, J. C. (2018) · Pain · doi:10.1097/j.pain.0000000000001270 · Cited by 52
The affective dimension of pain as a risk factor for drug and alcohol addiction
LeBlanc, D. M., McGinn, M. A., Itoga, C. A., & Edwards, S. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.005 · Cited by 48
“Interestingly, pain can also activate mesolimbic dynorphin/KOR systems to reduce dopamine levels (Narita et al., 2005), and this effect can blunt morphine reward.”
The application of conditioning paradigms in the measurement of pain
Li, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.002 · Cited by 43
“…in animals with formalin-, carrageenan- or complete Freund’s adjuvant-induced inflammatory pain, sciatic nerve ligation-induced neuropathic pain or cancer pain in both rats and mice (Betourne et al., 2008; Nakamura et al., 2008; Narita et al., 2005; Niikura et al., 2008; Suzuki et al., 1996).”
BackgroundNeuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems
Wawrzczak‐Bargieła, A., Ziółkowska, B., Piotrowska, A., Starnowska-Sokół, J., Rojewska, E., Mika, J., Przewłocka, B., & Przewłocki, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00166-4 · Cited by 46
“The proposed role of striatal dynorphins in chronic pain consists of attenuation of dopamine release via the presynaptic KOP receptor (Narita et al. 2005; Massaly et al. 2016).”
BackgroundInfluentialZiółkowska, B. (2021) · Brain Sciences · doi:10.3390/brainsci11101311 · Cited by 41
Pain-related cortico-limbic plasticity and opioid signaling
Neugebauer, V., Presto, P., Yakhnitsa, V., Antenucci, N., Mendoza, B., & Ji, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109510 · Cited by 46
Role of morphine, miR-212/132 and mu opioid receptor in the regulation of Bdnf in zebrafish embryos
Jiménez-González, A., García-Concejo, A., López‐Benito, S., González-Núñez, V., Arévalo, J. C., & Rodríguez, R. E. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.001 · Cited by 40
Miller, L. L., Altarifi, A., & Negus, S. S. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000042 · Cited by 38
“…in the acute abuse-related opioid effects in assays of opioid self-administration (Martin et al., 2007), opioid-induced place conditioning (Narita et al., 2004; Ozaki et al., 2003; Ozaki et al., 2002), and opioid-induced increases in nucleus accumbens dopamine release (Narita et al., 2004).”
BackgroundElectroacupuncture alleviates affective pain in an inflammatory pain rat model
Zhang, Y., Meng, X., Li, A., Xin, J., Berman, B., Lao, L., Tan, M., Ren, K., & Zhang, R. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.07.002 · Cited by 35
“Indeed, the extracellular level of dopamine in the nucleus accumbens, the major neural substrate for the rewarding effect produced by opioids, was markedly increased by 8 mg/kg, i.p. morphine in vehicle- but not formalin-injected rats (Narita et al., 2005).”
BackgroundNakamura, A., Narita, M., Miyoshi, K., Shindo, K., Okutsu, D., Suzuki, M., Higashiyama, K., & Suzuki, T. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1180-1 · Cited by 36
Self-citationPRECLINICAL STUDY: Mechanisms of respiratory insufficiency induced by methadone overdose in rats
Chevillard, L., Mégarbane, B., Baud, F. J., Risède, P., Declèves, X., Mager, D. E., Milan, N., & Ricordel, I. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00184.x · Cited by 31
“NTI (a delta-OR antagonist, 3 mg/kg) and nor-BNI (a kappa-OR antagonist, 5 mg/kg) were administered s.c. 6 hours and 45 minutes before methadone injection, respectively (Matsuzawa et al. 1998; Narita et al. 2005).”
BackgroundKatz, J. D., Pagé, M. G., Fashler, S. R., Rosenbloom, B. N., & Asmundson, G. J. G. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0414-9_8 · Cited by 36
Koren, D., Hemel, D., & Klein, E. (2006) · CNS Spectrums · doi:10.1017/s1092852900013675 · Cited by 32
Pahng, A. R., Paulsen, R. I., McGinn, M. A., Edwards, K. N., & Edwards, S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.055 · Cited by 30
Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
Doi, S., Mori, T., Uzawa, N., Arima, T., Takahashi, T., Uchida, M., Yawata, A., Narita, M., Uezono, Y., Suzuki, T., et al. (2016) · Molecular Pain · doi:10.1177/1744806916654146 · Cited by 28
“, Tokyo, Japan) as described previously.(14) To prevent tissue damage, we established a 30-s cut-off time.”
MethodSelf-citationA Leptin-Mediated Central Mechanism in Analgesia-Enhanced Opioid Reward in Rats
Lim, G., Kim, H., McCabe, M. F., Chou, C.-W., Wang, S., Chen, L. L., Marota, J. J. A., Blood, A. J., Breiter, H. C., & Mao, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0386-14.2014 · Cited by 31
“Previous studies have shown that persistent nociception in rats may decrease the antinociceptive effect of morphine (Mao et al., 1995; Narita et al., 2005) and that the expression of morphine reward could be masked by the development of morphine tolerance (Suzuki et al., 1996).”
BackgroundIn vivo effects of morphine on neuronal fate and opioid receptor expression in zebrafish embryos
Sánchez-Simón, F. M., Arenzana, F. J., & Rodríguez, R. E. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07317.x · Cited by 32
“…of MOR (the receptor to which morphine displays higher affinity) and KOR favours the differentiation of stem cells into neurons (Persson et al., 2003; Kim et al., 2006), and DOR is involved in neuroprotection and neurogenesis (Mayfield et al., 1996; Zhang et al., 2000; Narita et al., 2006).”
BackgroundMediterranean X Western based diets: Opposite influences on opioid reinstatement
Milanesi, L. H., Rossato, D. R., Dias, V. T., Kronbauer, M., D’avila, L. F., Somacal, S., Duarte, T., Duarte, M. M. F. M., Emanuelli, T., & Bürger, M. E. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.03.009 · Cited by 27
Nalbuphine is effective in decreasing the rewarding effect induced by morphine in rats
Tao, P., Liang, K.-W., Sung, W.-Y., Wu, Y.-T., & Huang, E. Y. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.01.013 · Cited by 26
Rosa, H. Z., Barcelos, R. C. S., Segat, H. J., Roversi, K., Dias, V. T., Milanesi, L. H., & Bürger, M. E. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.111 · Cited by 25
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
Reed, B., Butelman, E. R., & Kreek, M. J. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_401 · Cited by 25
Temporal Dynamics of Anxiety Phenotypes in a Dental Pulp Injury Model
Shang, L., Xu, T., Li, F. Y., Su, J., & Li, W. (2015) · Molecular Pain · doi:10.1186/s12990-015-0040-3 · Cited by 27
Bétourné, A., Familiades, J., Lacassagne, L., Halley, H., Cazalès, M., Ducommun, B., Lassalle, J. M., Zajac, J., & Francès, B. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.045 · Cited by 22
“A similar reduction of morphine-induced dopamine release was found in the limbic forebrain of rats under short-term inflammatory pain and was counteracted by the microinjection of dynorphin A antibodies in the Acb (Narita et al., 2005).”
Tokuyama, S., Nagae, R., Mashida, E., & Hamabe, W. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.8.0008 · Cited by 22
“In addition, Narita et al (2005) reported that chronic pain facilitates the endogenous kappa opioidergic system, suggesting the possibility of an involvement of KOR activation in chronic-pain-induced suppression of tolerance to morphine analgesia.”
BackgroundAnalgesic Drugs Combinations in the Treatment of Different Types of Pain
Ortiz, M. I., Molina, M. A. R., Arai, Y.-C. P., & Romanò, C. L. (2012) · Pain Research and Treatment · doi:10.1155/2012/612519 · Cited by 24
Massaly, N., Temp, J., Machelska, H., & Stein, C. (2020) · Pain · doi:10.1097/j.pain.0000000000001968 · Cited by 21
Yamaguchi, T., Narita, M., Morita, T., Kizawa, Y., & Matoba, M. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys155 · Cited by 25
“Peripheral nerve injury can cause sustained activation of the endogenous b-endorphinergic system in the brain. b-Endorphin released by chronic nociceptive stimuli can continuously activate m-opioid receptors in the ventral tegmental area (VTA), thus leading to downregulation of m-opioid receptor function and resulting…”
BackgroundInfluentialSelf-citationMori, T., Kanbara, T., Harumiya, M., Iwase, Y., Aki, M., Komiya, S., Nakamura, A., Shibasaki, M., Kanemasa, T., Sakaguchi, G., et al. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14134fp · Cited by 20
Self-citationMurphy, N. P. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500295q · Cited by 21
Wu, G., Huang, W., Zhang, H., Li, Q., Zhou, J. F., & Shu, H. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.041 · Cited by 19
Abdel-Ghany, R. H., Nabil, M., Abdel-Aal, M., & Barakat, W. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.062 · Cited by 19
The Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
Marchette, R. C. N., Vendruscolo, L. F., & Koob, G. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00618-x · Cited by 18
“This is evident in chronic pain models, where systemic KOR antagonism blocked the reduction of dopamine release in the nucleus accumbens in inflammatory pain [105].”
Barattini, A. E., Montanari, C., Edwards, K. N., Edwards, S., Gilpin, N. W., & Pahng, A. R. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109512 · Cited by 18
Niikura, K., Narita, M., Okutsu, D., Tsurukawa, Y., Nanjo, K., Kurahashi, K., Kobayashi, Y., & Suzuki, T. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.042 · Cited by 18
Self-citationHuerta, M. Á., Cisneros, E., Alique, M., & Roza, C. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105761 · Cited by 17
Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.
Neelakantan, H., Ward, S. J., & Walker, E. A. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000097 · Cited by 17
“…the presence of persistent inflammatory pain can up-regulate kappa-opioid receptors in the nucleus accumbens of the central reward circuitry (Narita et al., 2005; Suzuki, Kishimoto, Misawa, Nagase, & Takeda, 1999) and the presence of peripheral nerve injury via surgical manipulation can…”
BackgroundKappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy
Meade, J. A., Alkhlaif, Y., Contreras, K. M., Obeng, S., Toma, W. B., Sim‐Selley, L. J., Selley, D. E., & Damaj, M. I. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05572-2 · Cited by 18
“On the other hand, rats with partial nerve injury had attenuations in morphine-stimulated [35S]GTPγS binding in the VTA, morphine CPP, and morphine-stimulated dopamine release in the NAc (Ozaki et al. 2002), suggesting that neuropathy decreases morphine reward.”
BackgroundInfluentialKappa Opioid Receptor Function
Lemos, J. C., & Chavkin, C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_11 · Cited by 18
Campos-Jurado, Y., Lorente, J., González-Romero, J., Granero, L., Polache, A., & Hipólito, L. (2020) · Pain · doi:10.1097/j.pain.0000000000001915 · Cited by 13
Liu, X., Wang, N., Gu, L., Guo, J., Wang, J., & Luo, F. (2019) · Pain Research and Management · doi:10.1155/2019/6760121 · Cited by 18
Moerke, M. J., & Negus, S. S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107689 · Cited by 16
“…using both drug self-administration (Colpaert et al., 2001; Ewan and Martin, 2013; Kupers and Gybels, 1995) and conditioned-place-preference procedures (Lim et al., 2014; Narita et al., 2005; Niikura et al., 2008; Oe et al., 2004; Ozaki et al., 2003; Ozaki et al., 2002; Shippenberg et al., 1988).”
MethodOpioid and nondopamine reward circuitry and state‐dependent mechanisms
Fujita, M., Ide, S., & Ikeda, K. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13605 · Cited by 17
Homers at the Interface between Reward and Pain
Obara, I., Goulding, S. P., Gould, A. T., Lominac, K. D., Hu, J.-H., Zhang, P. W., von Jonquières, G., Dehoff, M. H., Xiao, B., Seeburg, P. H., et al. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00039 · Cited by 14
“In animal and human studies, noxious stimuli, including chronic constriction injury (CCI) of the sciatic nerve, alters the activational state of mesocorticolimbic circuit (e.g., Kuroda et al., 1995; Rodella et al., 1998; Narita et al., 2003, 2005; Ozaki et al., 2003, 2004; Wood et al., 2007).”
Milanesi, L. H., Roversi, K., Antoniazzi, C. T. D. D., Segat, H. J., Kronbauer, M., D’avila, L. F., Dias, V. T., Sari, M. H. M., Barcelos, R. C. S., Maurer, L. H., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.09.048 · Cited by 14
Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
Parker, K. E., Sugiarto, E., Taylor, A. M. W., Pradhan, A. A. A., & Al‐Hasani, R. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119438 · Cited by 14
“This is somewhat validated by many whom report reduced motivation for goaldirected behaviors during pain and has become a well-known feature of pain-induced negative affect (Narita et al., 2005; Michael D. Leitl et al., 2014; Schwartz et al., 2014; Hipólito et al., 2015; Liu et al., 2019; Massaly et al., 2019).”
BackgroundKappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction
Cahill, C. M., Lueptow, L. M., Kim, H., Shusharla, R., Bishop, A., & Evans, C. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_434 · Cited by 15
Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain
Lee, G. J., Kim, S. A., Kim, Y. J., & Oh, S. B. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147445 · Cited by 13
Effects of Combined Opioids on Pain and Mood in Mammals
Rech, R. H., Mokler, D. J., & Briggs, S. L. (2012) · Pain Research and Treatment · doi:10.1155/2012/145965 · Cited by 16
“[96, 97]).”
Massaly, N., Markovic, T., Creed, M. C., Al‐Hasani, R., Cahill, C. M., & Morón, J. A. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.002 · Cited by 15
Morgan, M., Herath, H. M. D. R., Cabot, P. J., Shaw, P. N., & Hewavitharana, A. K. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6406-8 · Cited by 12
Pain And Opioid Systems, Implications In The Opioid Epidemic
Massaly, N., & Morón, J. A. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.10.002 · Cited by 11
Briggs, S. L., & Rech, R. H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.12.023 · Cited by 11
Mi, W., Wang, S., You, Z., Lim, G., McCabe, M. F., Kim, H., Chen, L. L., & Mao, J. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002128 · Cited by 11
Henriksen, G., Willoch, F., Talbot, P. S., & Wester, H. (2006) · Drug Development Research · doi:10.1002/ddr.20161 · Cited by 10
“, m-OR-mediated) effect of morphine [Narita et al., 2005].”
BackgroundObesity-mediated Lipoinflammation Modulates Food Reward Responses
Huerta, C., Caba, M., & Camacho‐Morales, A. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.08.019 · Cited by 9
Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine
Torigoe, K., Mori, T., Shibasaki, M., Yoshizawa, K., Narita, M., & Suzuki, T. (2011) · Synapse · doi:10.1002/syn.21500 · Cited by 9
“We have proposed that the abuse potential of morphine is potently suppressed under chronic pain in rodents (Suzuki et al., 1996; Narita et al., 2005; Niikura et al., 2010).”
BackgroundSelf-citationLewandrowski, K., Fiorelli, R. K. A., Schmidt, S. L., Sharafshah, A., Baron, D. A., Gold, M. S., Thanos, P. K., Elman, I., Bagchi, D., Bowirrat, A., et al. (2025) · The International Journal of Spine Surgery · doi:10.14444/8756 · Cited by 8
Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism
Lee, Y. S., Remesic, M., Ramos-Colon, C. N., Wu, Z., LaVigne, J. E., Molnar, G., Tymecka, D., Misicka, A., Streicher, J. M., Hruby, V. J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9060625 · Cited by 8
Ahmadian-Moghadam, H., Sadat‐Shirazi, M., Seifi, F., Niknamfar, S., Akbarabadi, A., Toolee, H., & Zarrindast, M. (2019) · EXCLI journal · doi:10.17179/excli2019-1845 · Cited by 11
“Moreover, pain perception would cause sustained activation of kappa opioidergic system in the NAC that suppresses morphine which induces a rewarding effect (Narita et al., 2005).”
Hamabe, W., Yamane, H., Harada, S., & Tokuyama, S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.9.0010 · Cited by 7
“In addition, a condition of chronic pain caused the disappearance of the morphine-induced rewarding effect, which is an indicator of psychological dependence; this disappearance was prevented by KOR antagonists (Narita et al 2005).”
BackgroundKappa Opioid Antagonists: Past Successes and Future Prospects
Metcalf, M. D., & Coop, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_25 · Cited by 7
Fentanyl and Spiradoline Interactions in a Place-Conditioning Black-White Shuttle-Box
Rech, R. H., Briggs, S. L., & Mokler, D. J. (2010) · Pharmaceuticals · doi:10.3390/ph401101 · Cited by 6
“[27] noted that patients suffering from cancer pain appeared to develop less than normal psychological dependence upon morphine.”
BackgroundImaging opioid analgesia in the human brain
Lee, M., Wanigasekera, V., & Tracey, I. (2012) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2012.07.002 · Cited by 6
Morphine-induced cognitive impairment is attenuated by induced pain in rats.
Baiamonte, B. A., Lee, F. A., Gould, H. J., & Soignier, R. D. (2013) · Behavioral Neuroscience · doi:10.1037/a0033027 · Cited by 7
Yoshizawa, T., & Funahashi, M. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.11.002 · Cited by 5
Lopes, E. F., West, A. M., Locke, J. L., Holleran, K. M., Adrian, L. A., Dawes, M. H., Curry, A. M., McKelvey, H. A., Martin, T. J., & Jones, S. R. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00075 · Cited by 6
Barattini, A. E., Gilpin, N. W., & Pahng, A. R. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173890 · Cited by 5
Metadata
- Authors
- Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2004-07-14
- Volume
- 30
- Issue
- 1
- Pages
- 111-118
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1989362268
- Cited by
- 128
- References
- 21
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 10 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 7 · 2014: 11 · 2013: 7 · 2012: 7
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- morphine, kappa opioid receptor, mesolimbic dopamine system, inflammatory pain, formalin-induced pain, nor-binaltorphimine, nucleus accumbens, dopamine turnover, dynorphin A, place preference, morphine reward, psychological dependence, cancer pain
- MeSH terms
- Animals, Brain Chemistry, Conditioning, Operant, Dopamine, Dynorphins, Edema, Foot, Formaldehyde, Inflammation, Limbic System, Male, Microinjections, Morphine, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Reward, Rats, Sprague-Dawley, Receptors, Opioid, kappa, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.